Additional Proxy Soliciting Materials (definitive) (defa14a)
April 13 2021 - 4:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section
14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
☑
|
Filed by the Registrant
|
☐
|
Filed by a Party other
than the Registrant
|
|
CHECK THE APPROPRIATE BOX:
|
☐
|
|
Preliminary Proxy Statement
|
☐
|
|
Confidential, For Use of the Commission Only
(as permitted by Rule 14a-6(e)(2))
|
☐
|
|
Definitive Proxy Statement
|
☑
|
|
Definitive Additional Materials
|
☐
|
|
Soliciting Material Under Rule
14a-12
|
BioMarin Pharmaceutical Inc.
(Name of Registrant as Specified In Its
Charter)
(Name of Person(s) Filing Proxy
Statement, if Other Than the Registrant)
PAYMENT OF FILING FEE (CHECK THE APPROPRIATE
BOX):
|
☑
|
|
No fee
required.
|
☐
|
|
Fee computed on table below per Exchange Act Rules
14a-6(i)(1) and 0-11.
|
|
|
|
1)
Title of each class of securities to which transaction
applies:
|
|
|
|
2)
Aggregate number of securities to which transaction applies:
|
|
|
|
3)
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
|
|
|
|
4)
Proposed maximum aggregate value of transaction:
|
|
|
|
5) Total fee paid:
|
☐
|
|
Fee paid previously with
preliminary materials:
|
☐
|
|
Check box if any part of the fee is
offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing
for which the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the form or schedule and the
date of its filing.
|
|
|
|
1)
Amount previously paid:
|
|
|
|
2)
Form, Schedule or Registration Statement No.:
|
|
|
|
3)
Filing Party:
|
|
|
|
4) Date
Filed:
|
|
|
|
|
|
|
|
|
|
|
BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO, CA 94949
ATTN: G. ERIC DAVIS, EVP & GENERAL COUNSEL
|
Your Vote Counts!
BIOMARIN PHARMACEUTICAL INC.
2021 Annual Meeting
Vote by May 24, 2021
11:59 PM ET
|
|
|
|
|
|
|
FLASHID-JOB#
|
|
|
|
|
|
|
|
|
|
|
|
You invested in BIOMARIN PHARMACEUTICAL INC. and it's time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on May 25, 2021.
Get informed before you vote
View the Notice & Proxy Statement, Form 10-K, and CEO Stockholder Letter online OR you can receive a free paper or email copy of material(s) by requesting prior to May 11, 2021. If you would like to
request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
|
|
For complete information and to vote, visit www.ProxyVote.com
Control #
|
|
|
Smartphone users
Point your camera here and
vote without entering a
control number
|
|
|
|
Vote Virtually at the Meeting*
May 25, 2021
9:00 AM PDT
|
|
|
Meeting live via the Internet - please visit
www.virtualshareholdermeeting.com/BMRN2021
|
|
|
|
*
|
Please check the meeting materials for any special requirements for meeting attendance.
|
Vote at www.ProxyVote.com
|
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.
|
FLASHID-JOB#
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024